![Indonesia: 2006 Article IV Consultation and Fifth Post-Program Monitoring Discussions—Staff Report; Staff Supplement; Public Information Notice on the Executive Board Discussion; and Statement by the Executive Director for Indonesia in: IMF Staff Indonesia: 2006 Article IV Consultation and Fifth Post-Program Monitoring Discussions—Staff Report; Staff Supplement; Public Information Notice on the Executive Board Discussion; and Statement by the Executive Director for Indonesia in: IMF Staff](https://www.elibrary.imf.org/view/journals/002/2006/319/images/full-9781451818383_f0010-02.jpg)
Indonesia: 2006 Article IV Consultation and Fifth Post-Program Monitoring Discussions—Staff Report; Staff Supplement; Public Information Notice on the Executive Board Discussion; and Statement by the Executive Director for Indonesia in: IMF Staff
![PlasmaCap EBA: An innovative method of isolating plasma proteins from human plasma - Miller - 2023 - Vox Sanguinis - Wiley Online Library PlasmaCap EBA: An innovative method of isolating plasma proteins from human plasma - Miller - 2023 - Vox Sanguinis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/6969ea02-7aca-4914-aa04-517318540220/vox13388-fig-0001-m.jpg)
PlasmaCap EBA: An innovative method of isolating plasma proteins from human plasma - Miller - 2023 - Vox Sanguinis - Wiley Online Library
![Low immunoglobulin M memory B-cell percentage in patients with heterotaxy syndrome correlates with the risk of severe bacterial infection | Pediatric Research Low immunoglobulin M memory B-cell percentage in patients with heterotaxy syndrome correlates with the risk of severe bacterial infection | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpr.2015.221/MediaObjects/41390_2016_Article_BFpr2015221_Fig1_HTML.jpg)
Low immunoglobulin M memory B-cell percentage in patients with heterotaxy syndrome correlates with the risk of severe bacterial infection | Pediatric Research
![Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease - Kriván - 2022 - Vox Sanguinis - Wiley Online Library Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease - Kriván - 2022 - Vox Sanguinis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7c590b0d-cb7c-43fe-8e01-8b1c5d097c20/vox.v117.10.cover.jpg?trick=1684722669840)